{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:42:37Z","timestamp":1790289757008,"version":"4.1.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.carrev.2021.07.001","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T09:50:38Z","timestamp":1625737838000},"page":"32-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pushing TAVR Beyond the Boundaries of a Surgery-Capable Center: Malpractice or a Rescue Plan?"],"prefix":"10.1016","volume":"31","author":[{"given":"Samer","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2021.07.001_bb0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.carrev.2020.12.002","article-title":"Safety and operational efficiency of restructuring and redeploying a transcatheter aortic valve replacement service during the COVID-19 pandemic: the Oxford experience","volume":"31","author":"Joseph","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2021.07.001_bb0010","first-page":"1437","article-title":"2019 Canadian cardiovascular society position statement for transcatheter aortic valve implantation","volume":"35","author":"Asgar","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.carrev.2021.07.001_bb0015","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2021.07.001_bb0020","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1093\/eurheartj\/ehw190","article-title":"Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17 919 patients","volume":"37","author":"Eggebrecht","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2021.07.001_bb0025","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jcin.2015.12.023","article-title":"Changes in the pacemaker rate after transition from Edwards SAPIEN XT to SAPIEN 3 transcatheter aortic valve implantation: the critical role of valve implantation height","volume":"9","author":"De Torres-Alba","year":"2016","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838921005066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838921005066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:20:34Z","timestamp":1761560434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838921005066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":5,"alternative-id":["S1553838921005066"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2021.07.001","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pushing TAVR Beyond the Boundaries of a Surgery-Capable Center: Malpractice or a Rescue Plan?","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2021.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}